Autologous Chondrocyte Implantation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
Autologous chondrocyte implantation is a surgical technique used to repair damages in the articular cartilage. This implantation is carried out in two separate surgical technique. The major surgical method is an arthroscopic technique, during which a detailed evaluation of the joint is prepared and a cartilage bioscopy is conducted. The cells extracted in the biopsy are enzymatically treated to isolate the chondrocyte, which is the cartilage constructing cells of the body. The isolated cells are re-implanted into the damaged area within the joint in second technique. Autologous chondrocyte implantation allows patients suffering from articular cartilage damage to regain mobility. The overall success rate of autologous chondrocyte implantation surgery is nearly 85%.
Based on procedure type, the global autologous chondrocyte implantation market can be segmented into gel-type autologous chondrocyte implantation (GACI), matrix-type autologous chondrocyte implantation (MACI), and collagen-type autologous chondrocyte implantation (CACI). The gel-type autologous chondrocyte implantation segment is likely to expand at a significant pace during the forecast period as compared to the other segments, because many surgeon prefer the use of GACI process in repair of cartilage damage of the knee, as it is easy, quick and very effective for restoring patient knee function and also connection with the normal tissue is very smooth. In terms of materials used, the autologous chondrocyte implantation market can be segmented into collagen membrane, hyaluronan polymer, polylactin copolymer and polyglactin copolymer. The collagen membrane segment is expected to expand at a significant pace due to its wide availability. The collagen membrane acts as a strong barriers to prevent epithelial migration. It has quick regenerative features that heal the affected area. Increasing number of road accidents and industrial accidents and growing prevalence of osteoarthritis worldwide are primary factors driving the autologous chondrocyte implantation market. Additionally, growing sports activities has increased the number of injury. This has led to high incidence of various fracture-related problems. Moreover, according to the Truven Health Marketscan Database, more than 2.4 million procedures are performed annually around the globe to address ligament, cartilage, or tendon injuries in the knee. However, inadequate health care facilities, longer recovery process, poor or lack of reimbursement in developing countries are restraining the market in these countries.
In terms of region, the global autologous chondrocyte implantation market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global market. This region is projected to hold a significant share of the global market, due increase in orthopedic procedures and adoption of technologically advanced products. Moreover, growing prevalence of osteoarthritis in the U.S.is a major cause of disability. In 2012, osteoarthritis effected 20.0 million people and expected to reach 40.0 million over the next 10 year. Increasing adoption of different technique in knee surgeries for advanced health care and rising awareness regarding the treatment of knee injuries are boosting the market in Europe. Expansion of the health care sector and rise in geriatric population coupled with increasing demand for minimally invasive surgeries are key factors boosting the adoption of autologous chondrocyte implantation. Additionally, untapped developing economies such as China and India are projected to further propel the autologous chondrocyte implantation market. Advancements in surgeries, increasing per capita income and growing incidence of osteoarthritis are likely to augment the market for autologous chondrocyte implantation in Middle East & Africa during the forecast period.
Major players operating in the global autologous chondrocyte implantation market are B.Braun Melsungen AG, Zimmer Biomet Holding Inc., Smith & Nephew plc, Osiris Therapeutics, Inc., Stryker Corporation, and Vertical Corporation.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017